Dr Anup Rawool, Consultant in Clinical and Cancer Genetics at Sahyadri Hospitals, Pune, discusses innovative therapies and ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Protalix saw record revenue growth in 2024, driven by increased sales to Chiesi, Pfizer, and Brazil. The company aims to start a Phase 2 trial for PRX-115 in 2025.

Gaucher is a genetic disease where glucocerebroside accumulates in cells and certain organs, with symptoms including fatigue, anaemia, low blood platelet count and enlargement of the liver and spleen.

includes Gaucher’s Disease, Krabbe Disease, Hurler Disease, Hunter Disease, Neimann Pick disease. Cord Blood Stem Cell Transplants are a standard of care and curative for rare diseases of the ...

PLX READ THE FULL PLX RESEARCH REPORT 2024 Financial and Operational Review Protalix Biotherapeutics, Inc. (NYSE:PLX) announced 2024 financial and operational results in a March 17th, 2024 press ...

Gaucher disease (GD) is an inherited disorder caused by recessive ... However, several studies have reported that alterations in other cell organelles can also contribute to the pathology. For example ...

Initially, diagnosis was of chronic liver disease prompting a liver biopsy which revealed Gaucher cells. Genetic testing at age 6 confirmed GD1 with biallelic GBA1 mutations p.Asn409Ser and c.217delC.

Some common rare diseases include haemophilia, Pompe disease, thalassaemia, sickle cell anemia, and Gaucher’s disease. UN Resolution on Persons Living with a Rare Disease On 16 December 2021, the UN ...

In autoimmune hepatitis, your immune system destroys liver cells. This condition may be called type 1 or ... These include alpha-1antitrypsin deficiency, Gaucher disease, and cystic fibrosis-related ...